49315-008-03 |
49315-008 |
HUMAN PRESCRIPTION DRUG |
DOXORUBICIN HYDROCHLORIDE |
doxorubicin hydrochloride |
INJECTABLE, LIPOSOMAL |
INTRAVENOUS |
20200914 |
N/A |
ANDA |
ANDA212299 |
Zydus Lifesciences Limited |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (49315-008-03) / 10 mL in 1 VIAL, SINGLE-DOSE |
49315-009-07 |
49315-009 |
HUMAN PRESCRIPTION DRUG |
DOXORUBICIN HYDROCHLORIDE |
doxorubicin hydrochloride |
INJECTABLE, LIPOSOMAL |
INTRAVENOUS |
20200914 |
N/A |
ANDA |
ANDA212299 |
Zydus Lifesciences Limited |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (49315-009-07) / 25 mL in 1 VIAL, SINGLE-DOSE |
70710-1530-1 |
70710-1530 |
HUMAN PRESCRIPTION DRUG |
DOXORUBICIN HYDROCHLORIDE |
doxorubicin hydrochloride |
INJECTABLE, LIPOSOMAL |
INTRAVENOUS |
20200914 |
N/A |
ANDA |
ANDA212299 |
Zydus Pharmaceuticals USA Inc. |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1530-1) / 10 mL in 1 VIAL, SINGLE-DOSE |
70710-1531-1 |
70710-1531 |
HUMAN PRESCRIPTION DRUG |
DOXORUBICIN HYDROCHLORIDE |
doxorubicin hydrochloride |
INJECTABLE, LIPOSOMAL |
INTRAVENOUS |
20200914 |
N/A |
ANDA |
ANDA212299 |
Zydus Pharmaceuticals USA Inc. |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1531-1) / 25 mL in 1 VIAL, SINGLE-DOSE |